Home›People›Sam Searcy
SS

Sam Searcy

Chief Executive Officer, ClinTrial Research

ExecutiveDirector
Updated Nov 6, 2026·Latest SEC filing Oct 28, 2026·Suggest an edit

About Sam Searcy

Sam Searcy is the chief executive officer of ClinTrial Research, and a director. The company works with global sponsors on Phase I to IV clinical trials. Its base is the Research Triangle in North Carolina. Searcy's role covers company strategy, growth and long-term business direction.

On December 17, 2025, ClinTrial Research announced a growth equity round led by Tarsadia Investments. Searcy called it a vote of confidence from a respected industry leader.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Sam Searcy in the role, so the role may have started earlier or lasted longer.

ClinTrial Research, Inc. Current
Chief Executive Officer and director
2026 – Present · Holly Springs, NC
A clinical research site network that carries out Phase I to IV trials for sponsors and connects patients to studies.

Key Colleagues at Startups

The people Sam Searcy works with at each company, as listed on that company's latest Form D.

ClinTrial Research, Inc. · Form D, Oct 28, 2026
JY
Jennifer Yevoli
Chief Legal Officer and director
SG
RR
Rishi Reddy
Director
JS
Jay Santoro
Director
AR
Andrew Ritts
Director
GP
Gautam Patel
Director

Sam Searcy in the News

Sources

  1. SECClinTrial Research, Inc. Form D, filed Oct 28, 2026
  2. company siteClinTrial Research home page, Leadership
  3. company siteClinTrial Research, About Us
  4. wire releaseClinTrial Research and Tarsadia Investments Partner to Build Next Generation Site Network (PR Newswire, December 17, 2025)